In touch with psoriasis: Topical treatments and current guidelines

Journal of the European Academy of Dermatology and Venereology

Volumn 25, Issue SUPPL. 4, 2011, Pages 3-8

  Murphy, G ^a   Reich, K ^b  

^a BEAUMONT HOSPITAL   (Ireland)

^b Dermatologikum Hamburg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; CALCINEURIN INHIBITOR; COAL TAR; CORTISONE ACETATE PLUS NEOMYCIN; DITHRANOL; FUMARIC ACID; METHOTREXATE; TAZAROTENE; VITAMIN D;

CLINICAL FEATURE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; HUMAN; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSORIASIS; REVIEW;

ADMINISTRATION, TOPICAL; BETAMETHASONE; CALCITRIOL; DERMATOLOGIC AGENTS; HUMANS; PRACTICE GUIDELINES AS TOPIC; PSORIASIS;

EID: 79955410039     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04059.x     Document Type: Review

References (17)

1. National Psoriasis Foundation [WWW document] 2010. URL (last accessed 22 March 2011).
2. Weiss SC, Kimball AB, Liewehr DJ, Blauvelt A, Turner ML, Emanuel EJ,. Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol 2002; 47: 512-518.
3. Griffiths CE, Tranfaglia MG, Kang S,. Prolonged occlusion in the treatment of psoriasis: a clinical and immunohistologic study. J Am Acad Dermatol 1995; 32: 618-622.
4. Menter A, Cram DL,. The Goeckerman regimen in two psoriasis day care centers. J Am Acad Dermatol 1983; 9: 59-65. (Pubitemid 13068677)
5. Jordan WP Jr, Clarke AM, Hale RK,. Long-term modified Goeckerman regimen for psoriasis using an ultraviolet B light source in the home. J Am Acad Dermatol 1981; 4: 584-591. (Pubitemid 11079725)
6. Harber LC, Armstrong RB, Leach EE, Walther RR, Fleiss JL,. Preliminary report: modified Goeckerman therapy for hospitalized patients: ambulatory day care center and improved quantitative dosimetry. J Invest Dermatol 1981; 77: 162-166. (Pubitemid 12229319)
7. Weigand DA, Everett MA,. Clearing of resistant psoriasis with anthralin. Arch Dermatol 1967; 95: 554-559.
8. Ingram JT,. The approach to psoriasis. Br J Med 1953; 2: 591-594.
9. Mason AR, Mason J, Cork M, Dooley G, Edwards G,. Topical treatments for chronic plaque psoriasis (Review). The Cochrane Library 2009.
10. Anstey AV, Bibby AJ,. A pooled analysis of studies with a new cacipotriol/betamethasone two-compound product shows effective and rapid response in psoriasis vulgaris. Presented at the 62nd Annual Meeting of the American Academy of Dermatology (AAD) 2004. Poster P1.
11. Douglas WS, Poulin Y, Decroix J, et al. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Acta Derm Venereol 2002; 82: 131-135. (Pubitemid 34596689)
12. Kragballe K, van de Kerkhof PC,. Consistency of data in six phase III clinical studies of a two-compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasis. J Eur Acad Dermatol Venereol 2006; 20: 39-44.
13. Lebwohl M, Ting PT, Koo JYM,. Psoriasis treatment: traditional therapy. Ann Rheum Dis 2005; 64 (Suppl. 2): ii83-ii86. (Pubitemid 40288530)
14. Kragballe K, Austad J, Barnes L, et al. A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris. Br J Dermatol 2006; 154: 1155-1560.
15. Kragballe K, Austad J, Barnes L, et al. Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris. Dermatology 2006; 213: 319-326. (Pubitemid 44837020)
16. Menter A, Korman NJ, Elmets CA, et al. American Academy of Dermatology Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol 2009; 60: 643-659.
17. Nast A, Kopp I, Augustin M, et al. German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version). Arch Dermatol Res 2007; 299: 111-138. (Pubitemid 46835379)